Despite weak Q3 earnings, Bharat Petroleum (BPCL) draws attention from global brokerages. CLSA upgraded BPCL to ‘Hold with a ...
The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...
Sumeet Jain, senior research analyst at CLSA, shares his outlook for India's IT sector and names his top picks for the space.
CLSA has reiterated its bullish stance on Zomato, adding the stock to its "High Conviction Overweight" list and raising the ...
The brokerage firm has also added Zomato to its high conviction outperform list, saying the recent correction is a buying ...
On Thursday, CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from ...
This steady growth in HDFC Bank's core earnings - both NII and net profit - came in despite a marginal rise in NPAs and NPA ...
On Thursday, CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.12% of ...
HCLTech declared a dividend of Rs 18 per share, including a special Rs 6 per share dividend to commemorate 25 years since its ...
On Thursday, CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from ...